Corticobasal Degeneration clinical trials at UCSF

1 research study open to eligible people

Corticobasal degeneration is a disease that impacts brain function, affecting movement and speech. UCSF is hosting clinical trials, focusing on how this condition changes over time. The study integrates different research strategies to track brain changes in affected individuals.

Showing trials for

  • ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

    open to eligible people ages 18 years and up

    ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.

    San Francisco, California and other locations

Our lead scientists for Corticobasal Degeneration research studies include .

Last updated: